Almirall SA (ALMRY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 0 2 sessions, March 2, 2026 to October 6, 2026
Company Description
Almirall SA (OTC: ALMRY) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $3.0B.
This page collects what Stock Titan holds for ALMRY, including price data, latest news, and short interest trends.
Stock Performance
Almirall SA (ALMRY) closed at $13.69 on October 6, 2026.
ALMRY Metrics & Rankings
Price returns through October 6, 2026. Ranking links may use different dates.
Latest News
Almirall SA has 7 recent news articles. Key topics include conferences, clinical trial. View all ALMRY news →
SEC Filings
Short Interest History
Short interest in Almirall SA (ALMRY) currently stands at 1.0 thousand shares, a new position with no short interest reported in the previous period, representing 0.0% of the shares outstanding. Since February 2026, short interest has increased by 906.0%.
Days to Cover History
Days to cover for Almirall SA (ALMRY) currently stands at 2.5 days, down 41.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since February 2026, the figure has decreased by 41.8%. Across the settlements charted above, it has ranged from 2.5 to 4.3 days.
ALMRY Company Profile & Sector Positioning
Almirall SA (ALMRY) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ALMRY often look at related companies in the same sector, including Hypera SA (HYPMY), Curaleaf Holdings Inc (CURLF), Hikma Pharms PLC (HKMPY), Hikma Pharmaceuticals PLC (HKMPF), and Sumitomo Pharma Co (SMDPY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ALMRY's relative position within its industry.